← Back to Patent Explorer
US4395559A Expired / Lapsed US ⏱️ 0.0 years remaining

2,3-Indoledione derivatives

Assignee: Hoffmann La Roche Inc
•
Filing: 1980-12-01
•
Granted: 1983-07-26
•
Expires: 2000-12-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 2,3-Indoledione derivatives of the formula <IMAGE> I wherein R is isopropyl or tert.butyl, R1 is hydrogen or lower alkyl and R2 is lower alkyl or lower aralkyl, and their pharmaceutically acceptable acid addition salts, prepared from a compound of the formula <IMAGE> II wherein R3 is hydroxy and R4 is chlorine or bromine or R3 and R4, taken together, are oxygen, and R1 and R2 are as previously set forth, are described. The compounds of formula I and their pharmaceutically acceptable addition salts are useful as beta -adrenergic blocking agents and antihypertensive agents.

Inventors

  • 👤 Graham A. Fothergill
  • 👤 John M. Osbond

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 04:25
CPC Classifications
C; C07; C07D; C07D209/00; C07D209/02; C07D209/04; C07D209/30; C07D209/32; C07D209/38; A; A61; A61P; A61P9/00; A61P9/12

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 36 words
A compound of the formula ##STR10## wherein R is isopropyl or tert.butyl, R 1 is hydrogen or lower alkyl, and R 2 is lower alkly, benzyl or β-phenethyl, or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 36 words
A compound of the formula ##STR10## wherein R is isopropyl or tert.butyl, R 1 is hydrogen or lower alkyl, and R 2 is lower alkly, benzyl or β-phenethyl, or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 26 words
A compound in accordance with claim 1, wherein R 1 is hydrogen, and R 2 is lower alkyl, or a pharmaceutically acceptable acid addition salt thereof.
Claim 4
Dependent Claim 8 words
A compound in accordance with claim 1, 7-(3-tert.butylamino-2-hydroxypropoxy)-1-methyl-2,3-indoledione.
Claim 5
Dependent Claim 8 words
A compound in accordance with claim 1, 7-(3-tert.butylamino-2-hydroxypropoxy)-1,4-dimethyl-2,3-indoledione.
Claim 6
Dependent Claim 8 words
A compound in accordance with claim 1, 7-(2-hydroxy-3-isopropylaminopropoxy)-1,4-dimethyl-2,3-indoledione.
Claim 7
Dependent Claim 8 words
A compound in accordance with claim 1, 1-benzyl-7-(3-tert.butylamino-2-hydroxypropoxy)-4-methyl-2,3-indoledione.
Claim 8
Dependent Claim 44 words
A compound of the formula ##STR11## wherein R 1 is hydrogen or lower alkyl, R 2 is lower alkyl, benzyl or β-phenethyl, R 3 is hydroxy, and R 4 is chlorine or bromine, or R 3 and R 4 , taken together, are oxygen.
Claim 9
Dependent Claim 44 words
A compound of the formula ##STR11## wherein R 1 is hydrogen or lower alkyl, R 2 is lower alkyl, benzyl or β-phenethyl, R 3 is hydroxy, and R 4 is chlorine or bromine, or R 3 and R 4 , taken together, are oxygen.

References Cited (Backward Citations)

US1778174A Cited
GB1069343A Cited
US3825558A Cited
US4137331A Cited
US4212804A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-07-25 1987-01-24 1987-07-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-07-25 1991-01-24 1991-07-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-07-25 1995-01-24 1995-07-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag